← Leaderboards
Rafael Eduardo Campo
University Of Miami School Of Medicine
$718,808
Attributed
$718,808
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $284.7K · FY2007–17$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$718,808 · 2
By mechanism
R21$434,122 · 1
P30$284,686 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Carlos Singer$794,338
- Lisa R Metsch$46,121,041
- Myron D Ginsberg$30,587,118
- Margaret A Fischl$33,970,395
- Victoria B Mitrani$15,506,632
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseSpecimenResponseMethodologyHiv-1LeadLiteratureDiagnosisFrequencies (Time Pattern)EnrollmentGuidelinesHigh PrevalenceAntiretroviral ResistanceInfectionAdvocateClinical TrialsCaringClassAllelesDetectionBloodDrug ResistanceAnti-Retroviral AgentsAntiretroviral Therapy
Grant awards (3)
Clinical Sciences Core (Core C)$284,686
P30 · FY2017 · AI · contact PI
True prevalence of pre-existing reverse transcriptase inhibitor resistance in tre$189,476
R21 · FY2008 · AI · contact PI
True prevalence of pre-existing reverse transcriptase inhibitor resistance in tre$244,646
R21 · FY2007 · AI · contact PI